EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm
Portfolio Pulse from
The Schall Law Firm has announced a class action lawsuit against ESSA Pharma Inc. (NASDAQ: EPIX) for alleged securities fraud. Investors who purchased EPIX securities between December 12, 2023, and October 31, 2024, are encouraged to join the lawsuit before March 25, 2025.
March 14, 2025 | 8:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ESSA Pharma Inc. is facing a class action lawsuit for alleged securities fraud, which could negatively impact its stock price in the short term.
The announcement of a class action lawsuit for securities fraud is likely to create negative sentiment among investors, potentially leading to a decline in EPIX's stock price. Legal issues of this nature can cause uncertainty and risk, prompting investors to sell off shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100